Future Health Today Project Echo® Education Sessions – SGLT2 inhibitors

The Future Health Today Project ECHO® series for SGLT2 inhibitors for the management of type 2 diabetes is available now for registration.

7-8pm, Thursdays via Zoom

Series facilitated by Lauren Cussen, Academic GP

28 July 2022: SGLT2i for hyperglycaemia management in patients with type 2 diabetes
Expert: Shane Hamblin, Endocrinologist

11 August 2022: SGLT2i for type 2 diabetes management in patients at risk of, or diagnosed with, CVD
Expert: Ralph Audehm, Academic GP

25 August 2022: SGLT2i for type 2 diabetes management in patients diagnosed with CKD
Expert: Adam Flavell, Nephrologist

Participants will learn the latest evidence and complexities around the use of SGLT2 inhibitors for the management of type 2 diabetes. The hub and spoke model of Project ECHO® brings best practice care to the front line and enables faster intervention at the community level. It provides an opportunity for participants to share de-identified cases from their practice and receive advice and support from the general practice community and topic experts.

This series is intended for GPs, nurses, registrars and practice managers.

21 Jul 2022